Cargando…

Lithium-induced Hyperparathyroidism and Hypercalcemia

Lithium is one of the mainstays of treatment for bipolar disorder. Chronic lithium therapy can rarely lead to hypercalcemia secondary to lithium-induced hyperparathyroidism. We present a 66-year-old female patient with bipolar disorder on lithium therapy presenting with hypercalcemia. We discussed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Naramala, Srikanth, Dalal, Hussain, Adapa, Sreedhar, Hassan, Amir, Konala, Venu Madhav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609280/
https://www.ncbi.nlm.nih.gov/pubmed/31309015
http://dx.doi.org/10.7759/cureus.4590
_version_ 1783432283982659584
author Naramala, Srikanth
Dalal, Hussain
Adapa, Sreedhar
Hassan, Amir
Konala, Venu Madhav
author_facet Naramala, Srikanth
Dalal, Hussain
Adapa, Sreedhar
Hassan, Amir
Konala, Venu Madhav
author_sort Naramala, Srikanth
collection PubMed
description Lithium is one of the mainstays of treatment for bipolar disorder. Chronic lithium therapy can rarely lead to hypercalcemia secondary to lithium-induced hyperparathyroidism. We present a 66-year-old female patient with bipolar disorder on lithium therapy presenting with hypercalcemia. We discussed the pathophysiology and management of hyperparathyroidism and hypercalcemia in patients on chronic lithium therapy.
format Online
Article
Text
id pubmed-6609280
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-66092802019-07-15 Lithium-induced Hyperparathyroidism and Hypercalcemia Naramala, Srikanth Dalal, Hussain Adapa, Sreedhar Hassan, Amir Konala, Venu Madhav Cureus Endocrinology/Diabetes/Metabolism Lithium is one of the mainstays of treatment for bipolar disorder. Chronic lithium therapy can rarely lead to hypercalcemia secondary to lithium-induced hyperparathyroidism. We present a 66-year-old female patient with bipolar disorder on lithium therapy presenting with hypercalcemia. We discussed the pathophysiology and management of hyperparathyroidism and hypercalcemia in patients on chronic lithium therapy. Cureus 2019-05-02 /pmc/articles/PMC6609280/ /pubmed/31309015 http://dx.doi.org/10.7759/cureus.4590 Text en Copyright © 2019, Naramala et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Endocrinology/Diabetes/Metabolism
Naramala, Srikanth
Dalal, Hussain
Adapa, Sreedhar
Hassan, Amir
Konala, Venu Madhav
Lithium-induced Hyperparathyroidism and Hypercalcemia
title Lithium-induced Hyperparathyroidism and Hypercalcemia
title_full Lithium-induced Hyperparathyroidism and Hypercalcemia
title_fullStr Lithium-induced Hyperparathyroidism and Hypercalcemia
title_full_unstemmed Lithium-induced Hyperparathyroidism and Hypercalcemia
title_short Lithium-induced Hyperparathyroidism and Hypercalcemia
title_sort lithium-induced hyperparathyroidism and hypercalcemia
topic Endocrinology/Diabetes/Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609280/
https://www.ncbi.nlm.nih.gov/pubmed/31309015
http://dx.doi.org/10.7759/cureus.4590
work_keys_str_mv AT naramalasrikanth lithiuminducedhyperparathyroidismandhypercalcemia
AT dalalhussain lithiuminducedhyperparathyroidismandhypercalcemia
AT adapasreedhar lithiuminducedhyperparathyroidismandhypercalcemia
AT hassanamir lithiuminducedhyperparathyroidismandhypercalcemia
AT konalavenumadhav lithiuminducedhyperparathyroidismandhypercalcemia